Angela Zhou Ph.D.

Manager, Scientific Analysis and Insights CAS

Angela Zhou serves as the Executive Editor of CAS Insights and the Lead Scientist in Life Sciences at CAS. Dr. Zhou earned her Ph.D. in Molecular Pharmacology and Toxicology from the University of Southern California, followed by postdoctoral training in cell biology at Johns Hopkins School of Medicine and specialized research in cancer therapeutics at Harvard Medical School.

Prior to joining CAS, Dr. Zhou held faculty positions at Missouri State University and Denison University, concentrating on teaching and research of cancer biology, cell signaling and biochemistry. At CAS, she leads a multidisciplinary team of research and data scientists who leverage comprehensive scientific databases. Dr. Zhou’s unique blend of scientific expertise and data analytics leadership enables her team to deliver strategic intelligence, helping organizations navigate emerging trends and opportunities across chemistry, life sciences, and materials science.

Seminars

Wednesday 29th April 2026
From Targets to Therapies: GPCR-targeted Drug Discovery Trends Revealed by CAS Data
11:15 am
  • Conducting a large-scale, data-driven landscape analysis of GPCR-targeted drug discovery using the CAS Content Collection™
  • Characterizing temporal trends in GPCR research activity to show shifts in research emphasis that reflect increased interest in underexplored receptors and disease-focused targeting strategies
  • Evaluating how therapeutic strategies have diversified, revealing a professional from small-molecule approaches toward a broader range of modalities

Angela Zhu